Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Pancreatic cancer: Where are we now and where are we going?

Molecular profiling of pancreatic cancer in guiding tumour biology understanding and drug target discovery


28 Sep 2019


Pancreatic cancer: Where are we now and where are we going?


Tumour Site

Pancreatic Adenocarcinoma


David Tuveson


D.A. Tuveson

Author affiliations

  • Cancer Center, Cold Spring Harbor Laboratory, 11724 - New York/US


Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.